Protalix Biotherapeutics (PLX) had the highest return in December 1999 by a US stock in the Biotechnology Industry, returning 360.5%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Protalix Biotherapeutics (PLX) | December 1999 | 360.53% |
Imunon (IMNN) | December 1999 | 267.19% |
GT Biopharma (GTBP) | December 1999 | 265.55% |
Incyte (INCY) | December 1999 | 106.9% |
Neurocrine Biosciences (NBIX) | December 1999 | 102.04% |
Lisata Therapeutics (LSTA) | December 1999 | 87.5% |
Theriva Biologics (TOVX) | December 1999 | 66.67% |
Regeneron Pharmaceuticals (REGN) | December 1999 | 61.9% |
Biogen (BIIB) | December 1999 | 54.72% |
Soligenix (SNGX) | December 1999 | 41.94% |
Armata Pharmaceuticals (ARMP) | December 1999 | 41.57% |
Insmed (INSM) | December 1999 | 41.54% |
ImmuCell (ICCC) | December 1999 | 40.74% |
Myriad Genetics (MYGN) | December 1999 | 37.31% |
Amgen (AMGN) | December 1999 | 33.47% |
Vertex Pharmaceuticals (VRTX) | December 1999 | 32.08% |
United Therapeutics (UTHR) | December 1999 | 28.67% |
Abeona Therapeutics (ABEO) | December 1999 | 28% |
Lifecore Biomedical (LFCR) | December 1999 | 22.45% |
Opko Health (OPK) | December 1999 | 20% |
Tenax Therapeutics (TENX) | December 1999 | 20% |
Geron (GERN) | December 1999 | 17.44% |
Alkermes (ALKS) | December 1999 | 16.27% |
Gilead Sciences (GILD) | December 1999 | 14.86% |
BioCryst Pharmaceuticals (BCRX) | December 1999 | 14.29% |
